Nanostructured lipid carriers as a potential vehicle for Carvedilol delivery: Application of factorial design approach

65Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Present invention relates to design of nanostructured lipid carriers (NLC) to augment oral bioavailability of Carvedilol (CAR). In this attempt, formulations of CAR-NLCs were prepared with glyceryl-monostearate (GMS) as a lipid, poloxamer 188 as a surfactant and tween 80 as a co-surfactant using high pressure homogenizer by 23 factorial design approach. Formed CAR-NLCs were assessed for various performance parameters. Accelerated stability studies demonstrated negligible change in particle size and entrapment efficiency, after storage at specified time up to 3 months. The promising findings in this investigation suggest the practicability of these systems for enhancement of bioavailability of drugs like CAR.

Cite

CITATION STYLE

APA

Patil, G. B., Patil, N. D., Deshmukh, P. K., Patil, P. O., & Bari, S. B. (2016). Nanostructured lipid carriers as a potential vehicle for Carvedilol delivery: Application of factorial design approach. Artificial Cells, Nanomedicine and Biotechnology, 44(1), 12–19. https://doi.org/10.3109/21691401.2014.909820

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free